home / stock / adtx / adtx news


ADTX News and Press, ADiTx Therapeutics Inc. From 05/05/23

Stock Information

Company Name: ADiTx Therapeutics Inc.
Stock Symbol: ADTX
Market: NASDAQ
Website: aditxt.com

Menu

ADTX ADTX Quote ADTX Short ADTX News ADTX Articles ADTX Message Board
Get ADTX Alerts

News, Short Squeeze, Breakout and More Instantly...

ADTX - InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome Clinical Trial Agreement with Mayo Clinic

Aditxt (NASDAQ: ADTX) , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, and its subsidiary Adimune(TM) Inc. announced a clinical trial agreement with Mayo Clinic. The clinical trial, which is designed to advance clinical studi...

ADTX - Stem Cell Transplantation Shows Promise in Treating Autoimmune Disorders

Data from the National Stem Cell Foundation shows that almost 4% of the global population lives with an autoimmune disorder. In America, this figure as per the Autoimmune Association , adds up to about 50 million individuals. Of this number, roughly 75% are women. Autoimmune diseases are c...

ADTX - Organ Donation, Transplantation: Challenges and How We Can Help More Individuals

National Donate Life Month is celebrated every April, with events held throughout the month to increase awareness about organ donation. This month also encourages more individuals to register as donors while also honoring people who have changed lives by donating. The surgical procedures made ...

ADTX - InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering

Aditxt (NASDAQ: ADTX) , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced that it has closed on its previously announced registered direct offering. The company transacted the closing with a single healthcare-focused i...

ADTX - Aditxt Announces Closing of $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the closing of its previously announced registered direct offering with a single healthcare-focu...

ADTX - FENG, ALXO and GFAI among mid-day gainers

2023-04-21 13:53:45 ET Gainers: Presto Automation ( PRST ) +49% . CBL International Limited ( BANL ) +34% . EyePoint Pharmaceuticals EYPT +31% . Asset Entities ( ASST ) +25% . ContextLogic ( WISH ) +24% . Mullen Automotive ( MU...

ADTX - EyePoint, Tenaya top healthcare gainers; Aditxt, Ocuphire among losers

2023-04-21 10:03:36 ET Gainers: EyePoint Pharmaceuticals ( EYPT ) +19% . Tenaya Therapeutics ( TNYA ) +21% . Community Health Systems ( CYH ) +11% . NovaBay Pharmaceuticals ( NBY ) +11% . Aziyo Biologics ( AZYO ) +8% . Loser...

ADTX - EVBG and SATX among pre-market losers

2023-04-21 09:15:38 ET Satixfy Communications ( SATX ) -17% . Aditxt ( ADTX ) -11% . Everbridge ( EVBG ) -10% . Augmedix ( AUGX ) -7% . Sensei Biotherapeutics ( SNSE ) -7% . Blackboxstocks ( BLBX ) -6% . Big Lots ( ...

ADTX - InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M

Aditxt (NASDAQ: ADTX) , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has entered into a definitive agreement. The company announced a registered direct offering totaling $1.9 million; the agreement is with a si...

ADTX - Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional in...

Previous 10 Next 10